Quinzii Catarina M, DiMauro Salvatore, Hirano Michio
Department of Neurology, Columbia University Medical Center, New York, NY 10032, USA.
Neurochem Res. 2007 Apr-May;32(4-5):723-7. doi: 10.1007/s11064-006-9190-z. Epub 2006 Nov 10.
Ubiquinone (coenzyme Q(10) or CoQ(10)) is a lipid-soluble component of virtually all cell membranes and has multiple metabolic functions. Deficiency of CoQ(10) (MIM 607426) has been associated with five different clinical presentations that suggest genetic heterogeneity, which may be related to the multiple steps in CoQ(10) biosynthesis. Patients with all forms of CoQ(10) deficiency have shown clinical improvements after initiating oral CoQ(10) supplementation. Thus, early diagnosis is of critical importance in the management of these patients. This year, the first molecular defect causing the infantile form of primary human CoQ(10) deficiency has been reported. The availability of genetic testing will allow for a better understanding of the pathogenesis of this disease and early initiation of therapy (even presymptomatically in siblings of patients) in this otherwise life-threatening infantile encephalomyopathy.
泛醌(辅酶Q10或CoQ10)是几乎所有细胞膜的脂溶性成分,具有多种代谢功能。CoQ10缺乏症(MIM 607426)与五种不同的临床表现相关,提示存在基因异质性,这可能与CoQ10生物合成的多个步骤有关。所有形式的CoQ10缺乏症患者在开始口服补充CoQ10后均显示出临床改善。因此,早期诊断对这些患者的管理至关重要。今年,已报道了导致婴儿型原发性人类CoQ10缺乏症的首个分子缺陷。基因检测的应用将有助于更好地理解这种疾病的发病机制,并在这种可能危及生命的婴儿型脑病中尽早开始治疗(甚至在患者的无症状兄弟姐妹中进行症状前治疗)。